Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages
Varenicline is a widely used and effective drug for smoking cessation. We have previously reported experimental evidence suggesting that varenicline increases the risk of cardiovascular events. Varenicline progresses atherosclerotic plaque formation in apolipoprotein E knockout (ApoE KO) mice. This...
Saved in:
Main Authors: | Mitsuhisa Koga (Author), Yuki Kanaoka (Author), Koshun Inada (Author), Sai Omine (Author), Yasufumi Kataoka (Author), Atsushi Yamauchi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Varenicline aggravates atherosclerotic plaque formation in nicotine-pretreated ApoE knockout mice due to enhanced oxLDL uptake by macrophages through downregulation of ABCA1 and ABCG1 expression
by: Mitsuhisa Koga, et al.
Published: (2020) -
Varenicline is a smoking cessation drug that blocks alveolar expansion in mice intratracheally administrated porcine pancreatic elastase
by: Mitsuhisa Koga, et al.
Published: (2018) -
Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment
by: Federica Galimberti, et al.
Published: (2023) -
Elevated permeability of the blood-brain barrier in mice intratracheally administered porcine pancreatic elastase
by: Fuyuko Takata, et al.
Published: (2015) -
Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Karen Alejandra Méndez-Lara, et al.
Published: (2020)